Contract HT941024P0289

Medpharm Inc. · Department Of Defense · September 29, 2024

Small Business Set Aside - TotalFirm Fixed PriceNAICS 325413

Medpharm Inc. was awarded a federal contract by Department Of Defense (Defense Health Agency) on September 29, 2024 for $187,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Dededo, GU. It was awarded under a small business set-aside. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 8, 2025. If all options are exercised, the contract could reach $994,000.

Obligated to date
$187.0K
$186,994
Current value
$363.4K
Potential value
$994.4K
if all options exercised
Modifications
2
Latest December 8, 2025

Contract details

PIID
HT941024P0289
Award type
Purchase Order
Pricing
Firm Fixed Price
Set-aside
Small Business Set Aside - Total
Competition
Competed Under Sap
NAICS
325413 · In-Vitro Diagnostic Substance Manufacturing
Product / service
In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Place of performance
Dededo, GU
First action
September 29, 2024
Latest action
December 8, 2025

Description

MULTI MICROBIOLOGY SUPPLIES

Modification timeline

  • December 8, 2025
    Mod P00003 · Funding Only Action
    $363.4K
  • September 17, 2025
    Mod P00002 · Exercise An Option
    $363.4K
  • September 29, 2024
    Base award
    MULTI MICROBIOLOGY SUPPLY FOR USNH GUAM
    $176.4K

Similar contracts

RecipientAgencyDateObligated
Diasorin IncDepartment Of DefenseDecember 31, 2025$518.8K
BloodworksDepartment Of DefenseDecember 31, 2025$160.2K
Sl Meditech Co.Department Of DefenseDecember 31, 2025$151.6K
Alba Bioscience, Inc.Department Of DefenseDecember 31, 2025$163.2K
Werfen USA LlcDepartment Of DefenseDecember 31, 2025$18.1K
Immucor IncDepartment Of DefenseDecember 31, 2025$154.2K

Top contractors in NAICS 325413

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Biomerieux Inc182$25.50M
2Cepheid114$20.70M
3Roche Diagnostics Corporation125$13.00M
4Quest Diagnostics Incorporated8$4.31M
5Hologic Sales And Service, Llc39$3.88M
6Beckman Coulter, Inc28$3.40M
7Fisher Scientific Company L.L.C.52$3.04M
8Werfen USA Llc91$2.75M
9Diasorin Inc21$2.74M
10Abbott Laboratories Inc.10$2.69M

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract HT941024P0289?

Contract HT941024P0289 is a federal contract awarded to Medpharm Inc. by Department Of Defense on September 29, 2024 for $187,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 2 times since the base award.

Who won contract HT941024P0289?

Medpharm Inc. won contract HT941024P0289 from Department Of Defense.

How much is contract HT941024P0289 worth?

Contract HT941024P0289 has obligated $187,000 to date, with a total potential value of $994,000 if all options are exercised.